Suppr超能文献

国家药物处方中列出的抗生素药物相互作用的临床相关性:使用链接的英国初级保健和医院数据对年龄在 65-100 岁的患者进行的两项大型基于人群的病例对照研究的结果。

Clinical Relevance of Drug-Drug Interactions With Antibiotics as Listed in a National Medication Formulary: Results From Two Large Population-Based Case-Control Studies in Patients Aged 65-100 Years Using Linked English Primary Care and Hospital Data.

机构信息

Centre for Health Informatics & Health Data Research UK North, Division of Informatics, Imaging and Data Science, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.

Centre for Drug Safety Science, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.

出版信息

Clin Pharmacol Ther. 2023 Feb;113(2):423-434. doi: 10.1002/cpt.2807. Epub 2022 Dec 16.

Abstract

This study evaluated drug-drug interactions (DDIs) between antibiotic and nonantibiotic drugs listed with warnings of severe outcomes in the British National Formulary based on adverse drug reaction (ADR) detectable with routine International Classification of Diseases, Tenth Revision coding. Data sources were Clinical Practice Research Databank GOLD and Aurum anonymized electronic health records from English general practices linked to hospital admission records. In propensity-matched case-control study, outcomes were ADR or emergency admissions. Analyzed were 121,546 ADR-related admission cases matched to 638,238 controls. For most antibiotics, adjusted odds ratios (aORs) for ADR-related hospital admission were large (aOR for trimethoprim 4.13; 95% confidence interval (CI), 3.97-4.30). Of the 51 DDIs evaluated for ADR-related admissions, 38 DDIs (74.5%) had statistically increased aORs of concomitant exposure compared with nonexposure (mean aOR 3.96; range 1.59-11.42); for the 89 DDIs for emergency hospital admission, the results were 75 (84.3%) and mean aOR 2.40; range 1.43-4.17. Changing reference group to single antibiotic exposure reduced aORs for concomitant exposure by 76.5% and 83.0%, respectively. Medicines listed to cause nephrotoxicity substantially increased risks that were related to number of medicines (aOR was 2.55 (95% CI, 2.46-2.64) for current use of 1 and 10.44 (95% CI, 7.36-14.81) for 3 or more medicines). In conclusion, no evidence of substantial risk was found for multiple DDIs with antibiotics despite warnings of severe outcomes in a national formulary and flagging in electronic health record software. It is proposed that the evidence base for inclusion of DDIs in national formularies be strengthened and made publicly accessible and indiscriminate flagging, which compounds alert fatigue, be reduced.

摘要

本研究评估了英国国家处方集(British National Formulary)中列出的具有严重后果警告的抗生素和非抗生素药物之间的药物药物相互作用(DDI),这些药物相互作用可通过常规的国际疾病分类第十版编码检测到不良反应(ADR)。数据来源是临床实践研究数据库 GOLD 和 Aurum 匿名电子健康记录,这些记录来自英国常规实践并与住院记录相关联。在倾向匹配的病例对照研究中,结局是 ADR 或急诊入院。分析了 121546 例与 ADR 相关的入院病例,与 638238 例对照匹配。对于大多数抗生素,与 ADR 相关的住院治疗的调整后比值比(aOR)较大(甲氧苄啶的 aOR 为 4.13;95%置信区间(CI),3.97-4.30)。在评估与 ADR 相关的入院治疗的 51 种 DDI 中,38 种 DDI(74.5%)与同时暴露相比,具有统计学上增加的 aOR(平均 aOR 3.96;范围 1.59-11.42);对于 89 种与急诊住院相关的 DDI,结果为 75 种(84.3%)和平均 aOR 2.40;范围 1.43-4.17。将参考组更改为单独暴露于抗生素可使同时暴露的 aOR 分别降低 76.5%和 83.0%。被列为引起肾毒性的药物大大增加了与用药数量相关的风险(当前使用 1 种药物和 3 种或更多药物的 aOR 分别为 2.55(95%CI,2.46-2.64)和 10.44(95%CI,7.36-14.81))。总之,尽管英国国家处方集(British National Formulary)中有严重后果的警告,并在电子健康记录软件中标记,但没有发现抗生素与多种 DDI 相关的实质性风险证据。建议加强纳入国家处方集的 DDI 的证据基础,并使其公开可及且无差别标记,这会加剧警报疲劳。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85e/10107602/5921235756a7/CPT-113-423-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验